Description
BLOOD BANK REAGENTS
First action · last action
2022-11-01 · 2025-12-16
Transactions
7
First transaction's obligation
$29,533
Base + all options value (sum of deltas)
$109,315
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79721D0259
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-11-01+$29,533= $29,533
- Mod P000012023-10-24+$29,533= $59,065
- Mod P000022024-05-09-$2,404= $56,661
- Mod P000032024-10-11+$29,533= $86,194
- Mod P000042025-09-02-$5,069= $81,125
- Mod P000052025-10-27+$29,135= $110,259
- Mod P000062025-12-16-$1,342= $108,917
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-11-01 | +$29,533 | $29,533 | BLOOD BANK REAGENTS |
| Mod P00001· EXERCISE AN OPTION | 2023-10-24 | +$29,533 | $59,065 | BLOOD BANK REAGENTS |
| Mod P00002· FUNDING ONLY ACTION | 2024-05-09 | −$2,404 | $56,661 | BLOOD BANK REAGENTS |
| Mod P00003· EXERCISE AN OPTION | 2024-10-11 | +$29,533 | $86,194 | BLOOD BANK REAGENTS |
| Mod P00004· FUNDING ONLY ACTION | 2025-09-02 | −$5,069 | $81,125 | BLOOD BANK REAGENTS |
| Mod P00005· EXERCISE AN OPTION | 2025-10-27 | +$29,135 | $110,259 | BLOOD BANK REAGENTS |
| Mod P00006· FUNDING ONLY ACTION | 2025-12-16 | −$1,342 | $108,917 | BLOOD BANK REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI V6KNKL6BDHL7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0306 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $40,949 | FY2026 |
| 36C25926N0280 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $64,078 | FY2026 |
| 36C25726N0176 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $7,634 | FY2026 |
| 36C25726N0224 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $16,514 | FY2026 |
| 36C25626N0214 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $23,127 | FY2026 |
| 36C25026N0043 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $21,884 | FY2026 |
Other recipients under 6550 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626P0524 | ROCHE DIAGNOSTICS CORPORATION | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $134,375 | FY2026 |
| 36C25626N0450 | THE BLOOD CENTER | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $324,605 | FY2026 |
| 36C25626D0050 | THE BLOOD CENTER | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626N0432 | THE BLOOD CENTER | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $245,189 | FY2026 |
| 36C25626N0413 | TOSOH BIOSCIENCE, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $32,760 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25623F0067_3600_36F79721D0259_3600 · retrieved 2026-09-26.